GATTEI, VALTER
 Distribuzione geografica
Continente #
EU - Europa 496
NA - Nord America 435
AS - Asia 362
SA - Sud America 56
AF - Africa 15
OC - Oceania 1
Totale 1.365
Nazione #
US - Stati Uniti d'America 413
SG - Singapore 140
IT - Italia 112
IE - Irlanda 110
DE - Germania 67
SE - Svezia 63
CN - Cina 59
HK - Hong Kong 57
BR - Brasile 53
RU - Federazione Russa 38
IN - India 37
VN - Vietnam 34
GB - Regno Unito 24
UA - Ucraina 20
FR - Francia 14
CA - Canada 12
PL - Polonia 11
FI - Finlandia 10
KR - Corea 8
MX - Messico 8
LT - Lituania 7
AT - Austria 6
BD - Bangladesh 6
BJ - Benin 6
TR - Turchia 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
ES - Italia 3
HR - Croazia 3
JP - Giappone 3
UZ - Uzbekistan 3
EG - Egitto 2
ID - Indonesia 2
KE - Kenya 2
KG - Kirghizistan 2
NL - Olanda 2
PK - Pakistan 2
VE - Venezuela 2
AR - Argentina 1
BE - Belgio 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
JM - Giamaica 1
OM - Oman 1
PS - Palestinian Territory 1
TO - Tonga 1
TW - Taiwan 1
ZM - Zambia 1
Totale 1.365
Città #
Dublin 109
Hong Kong 57
Singapore 47
Jacksonville 41
Ashburn 38
Beijing 38
Novara 20
Los Angeles 19
Boardman 15
Piemonte 15
Lawrence 14
Princeton 14
New York 13
Chandler 12
Dearborn 12
Ho Chi Minh City 12
Moscow 12
Milan 11
Munich 11
Vercelli 11
São Paulo 10
Warsaw 10
Atlanta 8
Bremen 8
Denver 8
Helsinki 8
Seoul 8
Podenzano 7
Redondo Beach 7
Turin 7
Buffalo 6
Cotonou 6
London 6
Mexico City 6
Belo Horizonte 5
Chennai 5
Falkenstein 5
Frankfurt am Main 5
Hanoi 5
Montreal 5
Roseto degli Abruzzi 5
Santa Clara 5
Wilmington 5
Ann Arbor 4
Boston 4
Dallas 4
Manchester 4
Nuremberg 4
Orem 4
Seattle 4
Somaglia 4
Stockholm 4
Ankara 3
Brno 3
Brooklyn 3
Grafing 3
Gunzenhausen 3
Jackson 3
Palermo 3
Poplar 3
San Mateo 3
Tashkent 3
Tokyo 3
Toronto 3
Vilnius 3
Cagliari 2
Chicago 2
Cologno Monzese 2
Da Nang 2
Hackney 2
Hangzhou 2
Houston 2
Johannesburg 2
Lewisham 2
Norwalk 2
Rimini 2
Roubaix 2
San Francisco 2
Santana do Araguaia 2
Sorocaba 2
Suzano 2
Thái Bình 2
Turku 2
Vienna 2
Zagreb 2
Abadia de Goiás 1
Amsterdam 1
Angra dos Reis 1
Anápolis 1
Asti 1
Athens 1
Augusta 1
Bexley 1
Bishkek 1
Brandon 1
Brasília 1
Brussels 1
Camboriú 1
Campo Alegre de Lourdes 1
Campo Maior 1
Totale 801
Nome #
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the "Fondazione Italiana Linfomi" MCL-0208 trial 101
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 89
HIF-1α is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia 85
Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia 83
Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia 82
Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement 80
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression 77
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels 73
NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways 72
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 70
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab 69
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 62
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 61
Quality assessment for PCR-based minimal residual disease in Lymphoma: 10 Years of cross-laboratory standardization process within the fondazione italiana linfomi MRD network 59
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemia 55
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 54
XPO1 mutations identify early‐stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 52
Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial 45
Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real‐World” study 35
CD49d expression is included in a revised 4‐factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real‐world experience 34
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands 30
Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma 27
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA 1
Totale 1.396
Categoria #
all - tutte 8.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202130 0 0 0 0 0 3 8 0 8 3 8 0
2021/202257 0 0 3 4 5 0 3 0 4 2 14 22
2022/2023212 15 13 17 0 10 15 7 15 109 1 3 7
2023/2024106 8 13 9 6 13 1 16 0 0 0 10 30
2024/2025328 7 0 9 2 11 14 41 79 66 21 14 64
2025/2026523 51 40 53 128 173 78 0 0 0 0 0 0
Totale 1.396